A PYMNTS Company

New Zealand: Anti-competitive pharmaceutical agreement probed

By  |  February 26, 2013

New Zealand’s Commerce Commission has announced a probe into the nation’s pharmaceutical industry. While the Commission had originally ordered changes on the Community Pharmacy Services Agreement last July, the authority is now looking into whether certain clauses in that agreement were created in an attempt to fix prices of prescription medications. According to reports, the agreement prohibited the act of discounting prescription drugs at pharmacies. When the clause was contested by a pharmacy owner, the Commission removed the clauses last December on the basis the agreement was anticompetitive. Now, according to the authority, DHB Shared Services, which added the clauses, as well as the organizations that supported it, are now under investigation.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

     

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Full Content: Radio NZ

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.